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Introduction
Each year, an estimated 45,000 people in the United States become newly infected with HIV6. More than 90% of
these new infections are thought to originate with people who are infected with HIV but not receiving medical care 
for their infection. Some of these people have not yet been diagnosed, others have been diagnosed but were never
linked to medical care, and still others were linked to
medical care but were subsequently lost to medical 
follow-up. The most critical challenge for HIV prevention 
is to identify people with HIV infection who are not in
care; help them access care, where they can receive
treatment with antiretroviral therapy (ART); and help
them remain in care.
Partner services is a key strategy for identifying people 
with HIV infection – those with undiagnosed infection 
and those with previously diagnosed infection who are 
not receiving medical care – and helping them access
care and treatment. All persons with newly diagnosed 
HIV infection should receive partner services to help
them identify sex and drug-injection partners who may 
also be infected, or may be at very high risk for
becoming infected. The partners can then be notified of 
their potential exposure and offered HIV testing. Those 
who test positive for HIV can then be linked to HIV 
medical care and other services.
Partner services can also help persons living with HIV 
and their partners address other needs, such as
reducing behavioral risk for transmitting or acquiring
HIV; accessing treatment for mental health issues and
substance abuse; and obtaining social services to
address housing, transportation, and employment
issues. 
This report summarizes 2014 client-level partner
services data submitted by CDC-funded jurisdictions in
the United States and dependent areas (Puerto Rico and
U.S. Virgin Islands).
Methods
Health departments collect standardized, client-level, 
National HIV Prevention Program Monitoring & 
2 | P a g e 
Highlights of the Report* 
 35,692 index patients were identified across all 
HIV Partner Services programs.  
 Of the 30,648 index patients who were eligible1 , 
located and with a reported enrollment status, 
92% were interviewed for HIV Partner Services. 
 28,432 partners were named by index patients 
across all HIV Partner Services programs and 75% 
were initiated2  for HIV Partner Services. 
 Of the 17,544notifiable3 partners with valid data, 
99% were notified of their potential HIV 
exposure. 
 Of the 12,426 notified partners with HIV test 
information, 80% were tested for HIV. 
 Of the 7,981 partners tested with a documented 
HIV test result, 36% were newly identified4  as 
HIV-positive.  
 Of the 598 newly identified HIV positive partners 
with follow-up information, 87% were linked to 
HIV medical care5 . 
 
*Reported percentages were calculated based on individuals with 
valid data on the outcome and excludes those reported as pending, 
lost to follow-up,  don’t know, or missing. 
1  An index patient is eligible for partner services if he or she is not 
deceased, or out of jurisdiction at the time of report. 
2 Partners named, for whom a record was created in the NHM&E 
client-level partner services database in EvaluationWeb® .  It includes  
partners determined to be out of jurisdiction, deceased, not notifiable 
due to assessed risk for potential violence on the part of the index 
patient or the partner, or previously diagnosed with HIV infection. 
3  Partners that are not known to be HIV-positive, out of jurisdiction, 
deceased, or potentially violent. 
4  Partners who test positive for HIV infection after having no evidence 
of previous HIV diagnosis from cross-check with the health 
department surveillance  system; review of laboratory reports, 
medical records, or other available data sources (e.g., partner services 
database, evidence of previous treatment for HIV); or patient self-
report. 
5 The referring agency has confirmed that the client accessed the HIV 
medical care to which he or she was referred. 







               




   
  
 





   
  
  







            
          
  







   
   
 
  
Evaluation (NHM&E) data from their partner services programs and report them to CDC twice yearly for monitoring at
the national level. Data are reported through EvaluationWeb®, a web-based software tool made available to grantees
by CDC. The data undergo a quality assurance process and are then used to calculate program indicators at the
national and jurisdictional levels to assess each step of the partner services process. Indicators are stratified by 
age, gender, race/ethnicity, target population1, and geographic region as defined by the U.S. Census Bureau2. Risk 
data used to define target population is only required and reported for individuals diagnosed as HIV-positive.
This report includes all partner services cases opened during the period of January 1 – December 31, 2014.  The 
following partner services program indicators are reported:
1. Interview of index patients (partner elicitation)
 Percentage of located index patients who were interviewed for partner services
2. Partner notification
 Percentage of notifiable partners who were notified
3. Partner testing
 Percentage of notified partners who were tested
 Percentage of tested partners who had newly diagnosed HIV infection
4. Linkage to HIV medical care
 Percentage of partners with newly diagnosed HIV infection who were linked to HIV medical care
Indicators were calculated and reported for those records with complete and valid data.
Findings
This report summarizes 2014 client-level partner services data from 57 of the 61 CDC funded jurisdictions in the
United States and dependent areas (Puerto Rico and U.S. Virgin Islands). Data from four jurisdictions (Houston, 
Kansas, Texas and Wyoming) are not included in this report because data files were not received by the July 1, 
2015 EvaluationWeb® data transfer to CDC. The following flowchart represents the calculated index patient
indicators used to answer key partner services program evaluation questions. 
1 Target populations  are categorized as follows: Men who have sex with men and report injection drug use; Men who have sex with men; 
Transgender persons who report injection drug use; Transgender persons; Persons who inject drugs; Heterosexual males; Heterosexual 
females
2 U.S. geographic regions include the following Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York,
Pennsylvania, Rhode Island and Vermont; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North
Dakota, Ohio, South Dakota and Wisconsin; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, 
Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia and West Virginia; West: Alaska, 
Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington and Wyoming. U.S. Dependent 
Areas: Puerto Rico and the U.S. Virgin Islands






































Data Source: NHM&E Partner Services data 
(January 1, 2014- December 31, 2014) as of 












   
   
 
    
 
 
    
  
  
    
   
 






   
 
     






    
 
     
      
  
 
    
 
   
 
   
   
   
 
 
    
 
Index Patients
In 2014, a total of 35,692 index patients were identified by partner services programs after testing HIV-positive. Of
them, 35,017 (98%) were eligible for HIV partner services.  
	 Age: The largest percentage of index patients were in the age group 20-29 years (32%) followed by 30-39 
(25%). Only 3% of index patients were younger than 19 years (Table 2).
	 Gender: The majority of index patients were males (81%), with females and transgender persons accounting
for 17% and 1% respectively (Table 2).  
	 Race/Ethnicity: A large percentage of index patients were black/African American (45%), followed by white 
(29%), and Hispanic/Latino (18%) (Table 2).
	 U.S. Geographic Region: Almost half (49%) of the index patients lived in the South (Table 2). 
	 Target Population: Men who have sex with men (MSM) accounted for 38% of index patients in 2014. 
However, there was a large percentage (40%) of no risk/missing/invalid data reported (Table 2).
How Effective Are Partner Services Programs At Identifying And Interviewing Index Patients With HIV Infection?
 Indicator: Percentage of located index patients who were interviewed for partner services
A total of 31,140 (90%) index patients were located and of those 30,648 with a reported partner services enrollment
status, 28,133 (92%) were interviewed to elicit partner names and identify risk behavior.
	 Age: Index patients aged 13-19 were most often located and interviewed (95%), while those in the <13 age 
group had the lowest percentages located and interviewed (69% and 71%, respectively) (Table 2).
	 Gender: Females (90%) were located at approximately the same rate as males (89%), but females were 
interviewed more often (96%) than males (91%) (Table 2).
	 Race/Ethnicity: Blacks/African Americans were located and interviewed for partner services more frequently
(92% and 95%, respectively) than whites (88% and 89%) and Hispanics/Latinos at 89% for both located and
interviewed for partner services (Table 2).
	 U.S. Geographic Region: Ninety-four percent of index patients residing in the South were located for partner
services, with the lowest rate reported in the Midwest (76%). The U.S. Dependent Areas had the highest
percentage of partner services interviews conducted, 100%; while the West had the lowest, 73% (Table 2).
	 Target Population: Almost all MSM (96%), heterosexual men and heterosexual women were located for
partner services (97%). However, MSM index patients were interviewed (90%) less frequently than 
heterosexual men and heterosexual women (96% and 97%, respectively) (Table 2). 
Partners
A total of 28,432 partners were named by index patients in 57 partner services programs. The following flowchart
represents the calculated partner indicators used to answer key partner services program evaluation questions.





     
 
                          



































New Denom.=598 Not Linked to HIV 
Medical Care
78 (13%)
Data Source: NHM&E Partner Services data (January 1, 2014- 





















     
      
 
    
   
    
     
   
 




   
    
 
 
   
 
    
 
 




     
      
    
 
      
  
 
      
     
    
        
   
    
      
 
         
     
      
   
 
How Effective Are Partner Services Programs at Notifying Partners Of Their Potential HIV Exposure? 
 Indicator: Percentage of notifiable partners who were notified
Of the 28,432 partners that were named, 21,282 (75%) were initiated for partner services. Of the partners that were 
initiated for partner services 1,525 (8%) were excluded because they were either previously known to be HIV-positive, 
out of jurisdiction, deceased, or potentially violent. Another 1,436 records (7%) contained insufficient or invalid data.
The remaining 18,321 (92%) were considered notifiable. Of the 17,544 notifiable partners with valid data, a total of 
17,315 (99%) partners were notified of their potential HIV exposure.
	 Age: The majority of partners initiated for partner services were in the age groups 20-29 and 30-39 (34% and
24%, respectively). Although partners from all age groups were notified at a rate greater than 98%, those 
aged younger than 13 were notified 100% of the time (Table 4).
	 Gender: More males were initiated for partner services (78%) than females (16%). Male, female and 

transgender partners were notified at the rate of 98% or higher (Table 4).
 
	 Race/Ethnicity: Although more Blacks/African Americans were initiated for partner services (46%) than 
whites (26%) and Hispanics/Latinos (16%), the groups were all notified (99%) at the same rate (Table 4).
	 U.S. Geographic Region: The majority of partners initiated for partner services lived in the South (51%)
compared to the Northeast (21%), West (17%) and Midwest (10%) (Table 4).
	 Target Population: Risk data are only required for those partners who test positive. Of those with a complete 
risk profile, 19% of the named partners initiated for partner services were MSM (Table 4).
How Effective Are Partner Services Programs In Testing Notified Partners And Identifying HIV Infections? 
 Indicator 1: Percentage of notified partners who were tested
 Indicator 2: Percentage of tested partners who had newly diagnosed HIV infection
Of the 12,426 notified partners with valid testing data, 9,947 (80%) were tested for HIV (Table 3). Of the 7,981
partners tested with a documented HIV test result, 2,844 (36%) were newly identified as HIV-positive (Table 5).
	 Age: The percentage of notified partners tested for HIV was about 80% for all age groups except for those 
aged <13 where the rate was 57% (Table 4). Partners in the age group 40-49 had the highest percentage
newly identified as HIV-positive (41%) (Table 6).
	 Gender: The percentage of male and female partners tested for HIV were equal (82%), while the rate of 
testing for transgender partners was lower (30%) (Table 4). The percentage newly identified as HIV-positive 
was higher for male partners (39%) than female partners (25%) (Table 6). 
	 Race/Ethnicity: The rate at which black/African American partners (79%) were tested for HIV was slightly 
lower than that for whites (81%) and Hispanics/Latinos (82%). American Indians or Alaska Natives had the 
highest rate at 89% (Table 4). The percentage newly identified as HIV-positive was highest for black/African
American partners (42%) (Table 6).





     




   
   
 
 
      
      
 
  




   
  
 
   
  
 
     
              
 
    
   
                
     
      









	 U.S. Geographic Region: The U.S. Dependent Areas had the highest percentage of notified partners tested for
HIV (94%) and the Northeast had the lowest (57%) (Table 4). When excluding the U.S. Dependent Areas, the
South had the highest percentage of partners newly identified as HIV-positive (41%) and the Northeast had 
the lowest (13%) (Table 6).
	 Target Population: Risk data were only required and reported for partners newly diagnosed as HIV-positive. 
Of these data, 39% of MSM tested were newly identified as HIV-positive (Table 6).
How Effective Are Partner Services Programs In Linking HIV-Positive Partners To HIV Medical Care Services? 
 Indicator: Percentage of partners with newly diagnosed HIV infection who were linked to HIV medical care
Partners who test positive for HIV should be linked as soon as possible to HIV medical care. In 2014, a total of 2,844
partners were newly identified as HIV-positive from all partner services programs. Of the 598 newly identified HIV-
positive partners with follow-up information to verify that services were accessed, 520 (87%) were linked to HIV 
medical care (Table 5). 
	 Age: HIV-positive partners aged 40-49 had the highest linkage to HIV medical care at 90%. Partners aged 20­
29 and 30-39 were linked to HIV medical care at a rate of 87% (Table 6).  
	 Gender: Male and female HIV-positive partners had the same linkage to HIV medical care at 88%, however, 
only 40% of transgender partners were linked to HIV medical care (Table 6).
	 Race/Ethnicity: Black/African American HIV-positive partners (91%) were linked to HIV medical care at a 
higher rate than white (85%), Hispanic/Latino (78%) and multi-race (75%) partners (Table 6).
	 U.S. Geographic Region: Partners who lived in the South (94%) were linked more than those in the Northeast
(87%), the Midwest (77%) and the West (65%) (Table 6).
	 Target Populations: Among the newly identified HIV-positive partners who could be categorized as one of 
the listed target populations, all MSM/IDU (3) and Transgender/IDU (1) partners were linked to medical care. 
Heterosexual women (83%) were linked to medical care more often than MSM (78%) and heterosexual men 
(75%) (Table 6).
Limitations 
While partner services data reporting and quality are continuously improving, the interpretation of findings contained 
in this report has to be informed by the level of missing data on key variables and the factors that contributed to
missing data.





   
  
   
       
    
     










    
        





   
 







In the 2014 partner services data,  several key variables used to calculate program performance indicators had
missing data ranging between 2% and 79% of the total records.  
 Enrollment Status for Index Patients 2% 
 Partner Notifiability 7% 
 HIV Test Performed for Partners 28%
 Test Results for Partners 20%
 Linkage to HIV Medical Care 79%  
This report focuses on “reported” percentages calculated by excluding missing data, thus possibly overestimating the 
true values for the indicators.
In addition, other important variables that are required to describe the indicators by demographic and other
population groups (particularly behavioral risk) had significant levels of missing data. There are at least two factors
that contributed to missing data. The first is related to the varied data collection systems used by grantees.  Although 
the NHM&E required variables are standardized, health departments use different systems for collecting and
reporting partner services data. Sixty-one percent of grantees use their own locally developed or adapted systems
(e.g., PRISM, Maven, PartnerServicesWeb®) and 22% use some version of STD*MIS, a CDC-supported data collection 
tool. Versions prior to the most recent installment of STD*MIS did not capture 14 of the key variables needed to
calculate partner services program performance indicators and several grantees are still using these earlier versions. 
Other data systems were missing key identifying variables, such as case number that is needed for linking index 
patients to partners. HIV testing and referral to HIV medical care variables for newly identified HIV-positive partners
were also missing in some systems.
Secondly, tracking partners’ past and current HIV test results and their linkage to care and other services is a complex 
time and labor intensive activity. At a minimum, it requires data sharing between various providers and data systems
that are continuously updated.  While many health departments report linking 100% of their newly identified partners
to HIV medical care, their partner services data submitted to CDC do not reflect this for a variety of reasons. For
example, it is very likely that the high levels of missing data on linkage to HIV medical care is due to the lack of formal
systems to confirm if a person has indeed attended their first HIV medical appointment; or lack of a method to collect
information (no designated place to enter the data in the systems). This appears to be a recurring problem within 
partner services programs. 









        
          
          
          
          
          
           
             
             
          
          
          
          
          
           
             
          
          
          
             
          
          
          
          
          
          
             
          
          
          
          
          
          
  




Number of Index Patients 
Eligible for PS
Number of Index Patients 
Located 











Alabama 227 225 99.1 223 225 99.1 221 223 99.1
Alaska 71 71 100.0 71 71 100.0 68 71 95.8
Arizona 1,375 1,308 95.1 1,168 1,301 89.8 1,113 1,168 95.3
Arkansas 443 442 99.8 408 442 92.3 314 408 77.0
California (excl. Los Angeles & San Francisco) 1,666 1,666 100.0 1,567 1,666 94.1 273 1,567 17.4
Los Angeles 406 406 100.0 406 406 100.0 406 406 100.0
San Francisco 314 314 100.0 256 311 82.3 250 256 97.7
Colorado 329 328 99.7 324 328 98.8 296 324 91.4
Connecticut 162 161 99.4 155 161 96.3 138 149 92.6
Delaware 117 113 96.6 96 113 85.0 86 96 89.6
District of Columbia 218 161 73.9 34 133 25.6 33 34 97.1
Florida 7,053 7,053 100.0 6,252 7,044 88.8 6,252 6,252 100.0
Georgia (excl. Atlanta) 493 491 99.6 491 491 100.0 491 491 100.0
Atlanta 353 353 100.0 353 353 100.0 353 353 100.0
Hawaii 52 52 100.0 51 52 98.1 42 51 82.4
Idaho 31 31 100.0 20 31 64.5 18 20 90.0
Illinois (excl. Chicago) 1,910 1,572 82.3 741 1,572 47.1 546 628 86.9
Chicago 791 791 100.0 634 791 80.2 566 634 89.3
Indiana 53 53 100.0 52 53 98.1 25 25 100.0
Iowa 87 85 97.7 85 85 100.0 62 85 72.9
Kentucky 111 111 100.0 109 111 98.2 103 109 94.5
Louisiana 1,862 1,862 100.0 1,862 1,862 100.0 1,862 1,862 100.0
Maine 28 28 100.0 24 28 85.7 21 24 87.5
Maryland (excl. Baltimore) 1,102 1,102 100.0 1,101 1,102 99.9 1,101 1,101 100.0
Baltimore 497 497 100.0 497 497 100.0 497 497 100.0
Massachusetts 95 95 100.0 79 95 83.2 52 79 65.8
Michigan 748 730 97.6 638 722 88.4 542 638 85.0
Minnesota 522 520 99.6 452 519 87.1 325 452 71.9
Mississippi 305 305 100.0 301 305 98.7 301 301 100.0
Missouri 490 484 98.8 475 484 98.1 442 475 93.1
Montana 18 17 94.4 17 17 100.0 15 15 100.0








      
          
          
          
         
          
          
           
             
          
          
          
          
          
          
             
    
          
          
          
          
    
         
         
         
          
          
    












Number of Index Patients 
Eligible for PS
Number of Index Patients 
Located 











Nebraska 43 43 100.0 42 43 97.7 33 34 97.1
Nevada 781 772 98.8 748 768 97.4 723 748 96.7
New Hampshire 33 33 100.0 32 33 97.0 28 32 87.5
New Jersey 626 605 96.6 317 605 52.4 261 317 82.3
New Mexico 96 96 100.0 96 96 100.0 96 96 100.0
New York (excl. New York City) 799 767 96.0 616 767 80.3 525 603 87.1
New York City 2,710 2,669 98.5 2,465 2,669 92.4 2,372 2,465 96.2
North Carolina 2,422 2,394 98.8 2,387 2,394 99.7 2,382 2,387 99.8
North Dakota 42 42 100.0 42 42 100.0 10 10 100.0
Ohio 913 910 99.7 832 910 91.4 832 832 100.0
Oklahoma 244 240 98.4 240 240 100.0 230 236 97.5
Oregon 255 252 98.8 153 252 60.7 153 153 100.0
Pennsylvania (excl. Philadelphia) 163 161 98.8 150 158 94.9 122 144 84.7
Philadelphia 743 736 99.1 611 669 91.3 578 611 94.6
Rhode Island^ 4 4 100.0 4 4 100.0 4 4 100.0
South Carolina 701 701 100.0 688 701 98.1 580 688 84.3
South Dakota 18 18 100.0 18 18 100.0 18 18 100.0
Tennessee 444 444 100.0 444 444 100.0 442 444 99.5
Utah 58 51 87.9 51 51 100.0 45 51 88.2
Vermont 4 4 100.0 2 2 100.0 2 2 100.0
Virginia 673 664 98.7 615 664 92.6 549 615 89.3
Washington 995 990 99.5 805 929 86.7 495 524 94.5
West Virginia 59 57 96.6 57 57 100.0 57 57 100.0
Wisconsin 527 527 100.0 377 511 73.8 377 377 100.0
Puerto Rico 403 403 100.0 403 403 100.0 402 403 99.8
U.S. Virgin Islands 7 7 100.0 3 3 100.0 3 3 100.0
Total 35,692 35,017 98.1 31,140 34,804 89.5 28,133 30,648 91.8
#Reported denominator is the number of index patients with valid data on the outcome and excludes missing/invalid data. 
*Reported percentage was calculated based on individuals with valid data on the outcome and excludes missing/invalid data.
^Data reflect a partial submission.


























         
            
            
            
            
            
            
            
         
            
            
            
            
             
            
         
            
            
            
            
             
             
            
            
             
            
Table 2. Demographic and Risk Behavior Characteristics of Index Patients Offered Partner Services, 57 Health Departments, 2014




















<13 60 0.2 37 54 68.5 12 17 70.6
13-19 837 2.4 793 835 95.0 747 789 94.7
20-29 11,122 31.5 10,205 11,060 92.3 9,463 10,120 93.5
30-39 8,754 24.8 7,757 8,695 89.2 7,004 7,640 91.7
40-49 7,322 20.7 6,371 7,278 87.5 5,631 6,242 90.2
50+ 6,735 19.1 5,797 6,700 86.5 5,098 5,660 90.1
Missing/Invalid 187 0.5 180 182 98.9 178 180 98.9
Gender
Male 28,456 80.6 25,248 28,291 89.2 22,598 24,849 90.9
Female 6,087 17.2 5,476 6,059 90.4 5,148 5,387 95.6
Transgender 219 0.6 188 215 87.4 163 185 88.1
Other 3 0.0 3 3 100.0 3 3 100.0
Declined/Not Asked 211 0.6 195 206 94.7 191 194 98.5
Missing/Invalid 41 0.1 30 30 100.0 30 30 100.0
Race/Ethnicity
White 10,123 28.7 8,841 10,056 87.9 7,671 8,623 89.0
Black or African American 15,862 44.9 14,449 15,795 91.5 13,606 14,276 95.3
Hispanic or Latino 6,491 18.4 5,720 6,459 88.6 5,037 5,660 89.0
Asian 586 1.7 521 583 89.4 397 503 78.9
American Indian or Alaska Native 178 0.5 167 175 95.4 150 163 92.0
Native Hawaiian or Pacific Islander 63 0.2 55 63 87.3 47 55 85.5
Multi-Race 174 0.5 168 174 96.6 142 168 84.5
Declined 18 0.1 12 18 66.7 8 12 66.7
Don't Know 1,282 3.6 985 1,245 79.1 877 981 89.4
Missing/Invalid 240 0.7 222 236 94.1 198 207 95.7





   
  
     
         
         
            
            
            
            
            
          
            
            
         
            
            
             
            
            




























Northeast 5,263 14.9 4,455 5,191 85.8 4,103 4,430 92.6
Midwest 5,775 16.4 4,388 5,750 76.3 3,778 4,208 89.8
South 17,215 48.8 16,158 17,178 94.1 15,854 16,154 98.1
West 6,354 18.0 5,733 6,279 91.3 3,993 5,450 73.3
U.S. Dependent Areas 410 1.2 406 406 100.0 405 406 99.8
Target Population
MSM/IDU 539 1.5 510 533 95.7 424 509 83.3
MSM 13,557 38.4 13,042 13,526 96.4 11,734 13,014 90.2
Transgender/IDU 10 0.0 9 10 90.0 8 9 88.9
Transgender 213 0.6 183 209 87.6 159 180 88.3
IDU 525 1.5 479 521 91.9 445 477 93.3
Heterosexual Men 3,103 8.8 2,995 3,092 96.9 2,854 2,978 95.8
Heterosexual Women 3,070 8.7 2,971 3,061 97.1 2,880 2,968 97.0
No Risk/Missing/Invalid 14,000 39.7 10,951 13,852 79.1 9,629 10,513 91.6
Total 35,017 100.0 31,140 34,804 89.5 28,133 30,648 91.8
#Reported denominator is the number of index patients with valid data on the outcome and excludes missing/invalid data.
*Reported percentage was calculated based on individuals with valid data on the outcome and excludes missing/invalid data.
^Determined by comparing “birth gender” and “current gender”.
$As reported in the risk profile.




























           
           
           
           
            
              
              
           
           
           
           
           
           
              
           
           
           
              
           
           
           
           
           
           
              
           
           
           
           
           
           





















Alabama 309 309 309 100.0 309 309 100.0 147 148 99.3
Alaska 129 129 129 100.0 129 129 100.0 91 95 95.8
Arizona 603 502 603 83.3 436 439 99.3 54 54 100.0
Arkansas 131 131 131 100.0 131 131 100.0 42 43 97.7
California (excl. Los Angeles & San Francisco) 260 257 260 98.8 249 257 96.9 77 103 74.8
Los Angeles 503 282 474 59.5 282 282 100.0 162 282 57.4
San Francisco 209 209 209 100.0 209 209 100.0 12 16 75.0
Colorado 324 254 324 78.4 254 254 100.0 222 254 87.4
Connecticut 49 44 49 89.8 41 41 100.0 28 28 100.0
Delaware 71 57 71 80.3 53 55 96.4 18 18 100.0
District of Columbia 166 166 166 100.0 42 166 25.3 15 39 38.5
Florida 4,403 4,327 4,403 98.3 4,323 4,327 99.9 3,512 3,831 91.7
Georgia (excl. Atlanta) 352 292 348 83.9 292 292 100.0 150 292 51.4
Atlanta 242 167 203 82.3 167 167 100.0 66 126 52.4
Hawaii 46 44 46 95.7 44 44 100.0 15 15 100.0
Idaho 37 37 37 100.0 37 37 100.0 6 9 66.7
Illinois (excl. Chicago) 90 57 90 63.3 57 57 100.0 23 57 40.4
Chicago 199 199 199 100.0 199 199 100.0 93 105 88.6
Indiana 14 14 14 100.0 14 14 100.0 14 14 100.0
Iowa 58 58 58 100.0 58 58 100.0 44 58 75.9
Kentucky 164 164 164 100.0 164 164 100.0 20 36 55.6
Louisiana 863 633 863 73.3 633 633 100.0 155 633 24.5
Maine 14 14 14 100.0 14 14 100.0 7 9 77.8
Maryland (excl. Baltimore) 764 764 764 100.0 764 764 100.0 525 645 81.4
Baltimore 417 417 417 100.0 417 417 100.0 310 349 88.8
Massachusetts 79 79 79 100.0 79 79 100.0 37 44 84.1
Michigan 621 110 174 63.2 102 110 92.7 43 43 100.0
Minnesota 140 107 114 93.9 102 105 97.1 46 70 65.7
Mississippi 463 460 463 99.4 460 460 100.0 340 377 90.2
Missouri 572 362 552 65.6 277 281 98.6 165 245 67.3
Montana 30 26 30 86.7 26 26 100.0 16 16 100.0





   
   
     
           
         
           
        
           
           
           
              
           
       
           
           
           
           
              
           
           
          
           
           
    
          
          
          
           
           
    
           



























Nebraska 34 32 33 97.0 29 29 100.0 9 9 100.0
Nevada 541 538 539 99.8 535 538 99.4 467 528 88.4
New Hampshire 13 13 13 100.0 13 13 100.0 5 5 100.0
New Jersey 639 73 76 96.1 47 68 69.1 11 38 28.9
New Mexico 65 65 65 100.0 65 65 100.0 43 65 66.2
New York (excl. New York City) 638 598 638 93.7 394 398 99.0 212 255 83.1
New York City 2,030 1,767 2,030 87.0 1,480 1,498 98.8 216 696 31.0
North Carolina 764 764 764 100.0 764 764 100.0 673 764 88.1
North Dakota 16 10 16 62.5 9 9 100.0 8 9 88.9
Ohio 167 167 167 100.0 165 165 100.0 73 73 100.0
Oklahoma 368 306 324 94.4 302 303 99.7 166 178 93.3
Oregon 107 49 107 45.8 41 42 97.6 38 38 100.0
Pennsylvania (excl. Philadelphia) 58 58 58 100.0 58 58 100.0 10 10 100.0
Philadelphia 855 844 855 98.7 843 843 100.0 290 374 77.5
Rhode Island^ 70 70 70 100.0 70 70 100.0 49 49 100.0
South Carolina 507 506 506 100.0 506 506 100.0 469 506 92.7
South Dakota 15 13 13 100.0 13 13 100.0 6 13 46.2
Tennessee 470 470 470 100.0 448 470 95.3 15 16 93.8
Utah 268 268 268 100.0 268 268 100.0 268 268 100.0
Vermont 1 0 0 0.0 0 0 N/A 0 0 N/A
Virginia 311 311 311 100.0 311 311 100.0 144 150 96.0
Washington 573 300 317 94.6 171 171 100.0 118 118 100.0
West Virginia 42 42 42 100.0 42 42 100.0 27 27 100.0
Wisconsin 200 178 199 89.4 169 172 98.3 51 51 100.0
Puerto Rico 207 207 207 100.0 207 207 100.0 123 131 93.9
U.S. Virgin Islands 1 1 1 100.0 1 1 100.0 1 1 100.0
Total 21,282 18,321 19,846 92.3 17,315 17,544 98.7 9,947 12,426 80.0
#Reported denominator is the number of partners with valid data on the outcome and excludes missing/invalid data.
 
*Reported percentage was calculated based on individuals with valid data on the outcome and excludes missing/invalid data.
 
@Named partners initiated for partner services includes recoded data and record updates.
 
^ Data reflect a partial submission.
 
N/A- No named partners elicited from index patients.































            
               
               
               
               
               
               
               
            
               
               
               
                
               
            
               
               
               
               
                
                
               
               
                
               

























<13 122 0.6 120 122 98.4 120 120 100.0 39 68 57.4
13-19 463 2.2 424 441 96.1 403 410 98.3 247 312 79.2
20-29 7,150 33.6 6,379 6,789 94.0 6,168 6,235 98.9 3,641 4,506 80.8
30-39 5,105 24.0 4,424 4,800 92.2 4,249 4,308 98.6 2,552 3,166 80.6
40-49 3,297 15.5 2,791 3,025 92.3 2,685 2,723 98.6 1,660 2,048 81.1
50+ 2,830 13.3 2,259 2,524 89.5 2,173 2,206 98.5 1,374 1,630 84.3
Missing/Invalid 2,315 10.9 1,924 2,145 89.7 1,517 1,542 98.4 434 696 62.4
Gender
Male 16,622 78.1 14,341 15,524 92.4 13,553 13,732 98.7 7,758 9,475 81.9
Female 3,446 16.2 2,978 3,167 94.0 2,811 2,844 98.8 1,800 2,210 81.4
Transgender 591 2.8 483 588 82.1 468 478 97.9 138 458 30.1
Declined/Not Asked 618 2.9 514 562 91.5 478 485 98.6 250 282 88.7
Missing/Invalid 5 0.0 5 5 100.0 5 5 100.0 1 1 100.0
Race/Ethnicity
White 5,607 26.3 4,832 5,192 93.1 4,563 4,616 98.9 2,616 3,227 81.1
Black or African American 9,783 46.0 8,484 9,145 92.8 8,103 8,209 98.7 4,758 6,008 79.2
Hispanic or Latino 3,316 15.6 2,872 3,130 91.8 2,690 2,709 99.3 1,643 2,007 81.9
Asian 204 1.0 173 182 95.1 149 152 98.0 80 98 81.6
American Indian or Alaska Native 124 0.6 109 113 96.5 108 108 100.0 76 85 89.4
Native Hawaiian or Pacific Islander 33 0.2 31 31 100.0 29 30 96.7 19 22 86.4
Multi-Race 107 0.5 98 102 96.1 94 94 100.0 39 48 81.3
Declined 36 0.2 28 30 93.3 21 22 95.5 9 18 50.0
Don't Know 1,498 7.0 1,209 1,427 84.7 1,100 1,140 96.5 425 613 69.3
Missing/Invalid 574 2.7 485 494 98.2 458 464 98.7 282 300 94.0





    
    
       
            
            
               
               
               
               
                
             
               
               
        
               
               
                
                
               
            




































Northeast 4,446 20.9 3,560 3,882 91.7 3,039 3,082 98.6 865 1,508 57.4
Midwest 2,126 10.0 1,307 1,629 80.2 1,194 1,212 98.5 575 747 77.0
South 10,807 50.8 10,286 10,719 96.0 10,128 10,281 98.5 6,794 8,178 83.1
West 3,695 17.4 2,960 3,408 86.9 2,746 2,761 99.5 1,589 1,861 85.4
U.S. Dependent Areas 208 1.0 208 208 100.0 208 208 100.0 124 132 93.9
Target Population
MSM/IDU 146 0.7 122 129 94.6 115 117 98.3 60 83 72.3
MSM 4,020 18.9 3,341 3,580 93.3 3,203 3,232 99.1 1,834 2,203 83.3
Transgender/IDU 3 0.0 2 3 66.7 2 2 100.0 2 2 100.0
Transgender 589 2.8 482 586 82.3 467 477 97.9 136 456 29.8
IDU 108 0.5 77 84 91.7 73 74 98.6 43 52 82.7
Heterosexual Men 903 4.2 698 744 93.8 680 688 98.8 439 530 82.8
Heterosexual Women 1,011 4.8 805 849 94.8 776 789 98.4 474 561 84.5
No Risk/Missing/Invalid 14,502 68.1 12,794 13,871 92.2 11,999 12,165 98.6 6,959 8,539 81.5
Total 21,282 100.0 18,321 19,846 92.3 17,315 17,544 98.7 9,947 12,426 80.0
Reported denominator is the number of partners with valid data on the outcome and excludes missing/invalid data. 
*Reported percentage was calculated based on individuals with valid data on the outcome and excludes missing/invalid data.
@Named partners initiated for partner services includes recoded data and record updates.
^Determined by comparing “birth gender” and “current gender”.
$As reported in the risk profile.























        
        
        
        
          
           
           
        
        
        
        
        
        
           
        
        
         
           
        
        
        
        
        
        
           
        
        
        
        






Newly Identified Partners Attended










Alabama 147 0 0 N/A 0 0 N/A
Alaska 91 0 0 N/A 0 0 N/A
Arizona 54 10 45 22.2 0 9 0.0
Arkansas 42 1 1 100.0 0 0 0.0
California (excl. Los Angeles & San Francisco) 77 8 76 10.5 0 1 0.0
Los Angeles 162 30 158 19.0 11 26 42.3
San Francisco 12 0 11 0.0 0 0 N/A
Colorado 222 38 211 18.0 35 35 100.0
Connecticut 28 0 28 0.0 0 0 N/A
Delaware 18 0 18 0.0 0 0 N/A
District of Columbia 15 4 8 50.0 1 1 100.0
Florida 3,512 1,112 3,310 33.6 25 26 96.2
Georgia (excl. Atlanta) 150 35 117 29.9 0 0 0.0
Atlanta 66 12 38 31.6 0 0 0.0
Hawaii 15 1 15 6.7 0 1 0.0
Idaho 6 0 0 N/A 0 0 N/A
Illinois (excl. Chicago) 23 0 23 0.0 0 0 N/A
Chicago 93 1 1 100.0 0 0 0.0
Indiana 14 5 10 50.0 5 5 100.0
Iowa 44 3 33 9.1 1 2 50.0
Kentucky 20 1 1 100.0 0 0 0.0
Louisiana 155 9 152 5.9 1 9 11.1
Maine 7 0 0 N/A 0 0 N/A
Maryland (excl. Baltimore) 525 308 480 64.2 154 155 99.4
Baltimore 310 184 286 64.3 82 82 100.0
Massachusetts 37 0 2 0.0 0 0 N/A
Michigan 43 9 42 21.4 0 5 0.0
Minnesota 46 7 45 15.6 1 2 50.0
Mississippi 340 126 320 39.4 3 3 100.0





















      
     
   
    
  
     
      
        
           
        
   
        
      
     
    
           
     
      
   
    
    
   
   
    
   
     
    
   
        











Newly Identified Partners Attended










Missouri 165 16 141 11.3 0 0 0.0
Montana 16 7 16 43.8 3 4 75.0
Nebraska 9 3 9 33.3 0 0 0.0
Nevada 467 0 0 N/A 0 0 N/A
New Hampshire 5 0 0 N/A 0 0 N/A
New Jersey 11 1 11 9.1 0 0 0.0
New Mexico 43 18 43 41.9 1 1 100.0
New York (excl. New York City) 212 30 202 14.9 13 15 86.7
New York City 216 40 207 19.3 30 33 90.9
North Carolina 673 372 673 55.3 70 83 84.3
North Dakota 8 1 8 12.5 0 0 0.0
Ohio 73 55 73 75.3 50 51 98.0
Oklahoma 166 40 165 24.2 9 9 100.0
Oregon 38 9 37 24.3 0 0 0.0
Pennsylvania (excl. Philadelphia) 10 0 0 N/A 0 0 N/A
Philadelphia 290 31 290 10.7 21 25 84.0
Rhode Island^ 49 4 49 8.2 3 4 75.0
South Carolina 469 289 454 63.7 0 0 0.0
South Dakota 6 1 4 25.0 0 0 0.0
Tennessee 15 2 7 28.6 0 0 0.0
Utah 268 0 0 N/A 0 0 N/A
Vermont 0 0 0 N/A 0 0 N/A
Virginia 144 1 4 25.0 0 0 0.0
Washington 118 8 100 8.0 1 1 100.0
West Virginia 27 0 0 N/A 0 0 N/A
Wisconsin 51 9 51 17.6 0 9 0.0
Puerto Rico 123 2 5 40.0 0 0 0.0
U.S. Virgin Islands 1 1 1 100.0 0 1 0.0
Total 9,947 2,844 7,981 35.6 520 598 87.0
#Reported denominator is the number of partners with valid data on the outcome and excludes missing/invalid data. 
*Reported percentage was calculated based on individuals with valid data on the outcome and excludes missing/invalid data.
^ Data reflect a partial submission.



























         
            
            
            
            
            
            
            
         
            
            
            
             
            
         
            
            
            
            
             
             
            
            
            
            
Table 6. Demographic and Risk Behavior Characteristics of Newly-Identified HIV+ Partners Linked to HIV Medical Care, 57 Health Departments, 2014






Newly Identified Partners Attended













<13 39 0.4 6 29 20.7 0 0 0.0
13-19 247 2.5 45 205 22.0 12 15 80.0
20-29 3,641 36.6 1,046 2,994 34.9 216 248 87.1
30-39 2,552 25.7 756 2,080 36.3 134 154 87.0
40-49 1,660 16.7 565 1,394 40.5 94 104 90.4
50+ 1,374 13.8 414 1,130 36.6 62 74 83.8
Missing/Invalid 434 4.4 12 149 8.1 2 3 66.7
Gender
Male 7,758 78.0 2,446 6,287 38.9 431 490 88.0
Female 1,800 18.1 373 1,500 24.9 87 99 87.9
Transgender 138 1.4 17 133 12.8 2 5 40.0
Declined/Not Asked 250 2.5 8 61 13.1 0 4 0.0
Missing/Invalid 1 0.0 0 0 0.0 0 0 N/A
Race/Ethnicity
White 2,616 26.3 614 2,110 29.1 110 130 84.6
Black or African American 4,758 47.8 1,707 4,093 41.7 330 363 90.9
Hispanic or Latino 1,643 16.5 415 1,300 31.9 63 81 77.8
Asian 80 0.8 9 55 16.4 2 2 100.0
American Indian or Alaska Native 76 0.8 12 44 27.3 2 2 100.0
Native Hawaiian or Pacific Islander 19 0.2 4 11 36.4 0 1 0.0
Multi-Race 39 0.4 8 27 29.6 3 4 75.0
Declined 9 0.1 2 9 22.2 0 0 0.0
Don't Know 425 4.3 69 286 24.1 10 14 71.4
Missing/Invalid 282 2.8 4 46 8.7 0 1 0.0























         
            
            
            
            
            
          
            
            
            
            
            
            
            
            
         
 
















Newly Identified Partners Attended













Northeast 865 8.7 106 789 13.4 67 77 87.0
Midwest 575 5.8 110 440 25.0 57 74 77.0
South 6,794 68.3 2,496 6,034 41.4 345 368 93.8
West 1,589 16.0 129 712 18.1 51 78 65.4
U.S. Dependent Areas 124 1.2 3 6 50.0 0 1 0.0
Target Population
MSM/IDU 60 0.6 10 43 23.3 3 3 100.0
MSM 1,834 18.4 608 1,579 38.5 109 139 78.4
Transgender/IDU 2 0.0 1 1 100.0 1 1 100.0
Transgender 136 1.4 16 132 12.1 1 4 25.0
IDU 43 0.4 11 37 29.7 1 3 33.3
Heterosexual Men 439 4.4 121 387 31.3 30 40 75.0
Heterosexual Women 474 4.8 135 409 33.0 33 40 82.5
No Risk/Missing/Invalid 6,959 70.0 1,942 5,393 36.0 342 368 92.9
Total 9,947 100.0 2,844 7,981 35.6 520 598 87.0
#Reported denominator is the number of partners with valid data on the outcome and excludes missing/invalid data. 
*Reported percentage was calculated based on individuals with valid data on the outcome and excludes missing/invalid data.
^Determined by comparing “birth gender” and “current gender”.
$As reported in the risk profile.
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